COR logo Cencora +
Cencora
+

Cencora (COR) Business News

Track Cencora in real time with a live news feed covering Cencora stock news, official press releases, company announcements, and an archive of historical Cencora news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha

12:25 PM | Tuesday | Sep 8, 2026

news photo
Loading...

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Read full article redirect
12:25 PM | Tuesday | Sep 8, 2026

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Read full article arrow
News Thumbnail
12:25 PM | Tuesday | Sep 8, 2026

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Read full article arrow
News Thumbnail
10:45 AM | Monday | Sep 7, 2026

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read full article arrow
News Thumbnail
12:36 PM | Friday | Sep 4, 2026

Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Read full article arrow
News Thumbnail
10:56 AM | Friday | Sep 4, 2026

Cencora Launches Cell and Gene Therapy Enablement for Health Systems

Zacks Investment Research

COR launches CGT Enablement to help health systems build and scale cell and gene therapy programs with financial, operational and access support.

Read full article arrow
News Thumbnail
4:56 PM | Thursday | Sep 3, 2026

Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen

Zacks Investment Research

Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.

Read full article arrow
News Thumbnail
8:30 AM | Wednesday | Sep 2, 2026

Cencora's Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs

Business Wire

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora today launched a service to help health systems evaluate, build and scale cell and gene therapy (CGT) programs. Offered through Accelerate Pharmacy Solutions, Cell and Gene Therapy Enablement is designed to help health systems strengthen operational readiness and program execution to reduce barriers to care and expand patient access to advanced therapies. “Cell and gene therapies have the potential to transform care for patients with serious and compl.

Read full article arrow
News Thumbnail
5:13 AM | Monday | Aug 31, 2026

Connor Clark & Lunn Investment Management Ltd. Invests $841,000 in Cencora, Inc. $COR

Defense World

Connor Clark and Lunn Investment Management Ltd. acquired a new stake in shares of Cencora, Inc. (NYSE: COR) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,973 shares of the company's stock, valued at approximately $841,000. Several other

Read full article arrow
News Thumbnail
2:22 PM | Sunday | Aug 23, 2026

Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance

Seeking Alpha

Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the second quarter. The fund was underweight in the communication services, health care and consumer discretionary sectors. Strong stock selection and an overweight in IT added to relative return. Weakness in energy partially offset the favorable results.

Read full article arrow
News Thumbnail
3:10 AM | Saturday | Aug 22, 2026

Advisors Capital Management LLC Takes $748,000 Position in Cencora, Inc. $COR

Defense World

Advisors Capital Management LLC purchased a new stake in shares of Cencora, Inc. (NYSE: COR) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,644 shares of the company's stock, valued at approximately $748,000. Several other hedge funds and

Read full article arrow
News Thumbnail
7:50 AM | Wednesday | Aug 19, 2026

"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.

Fool - Investing News

These healthcare companies can actually benefit from inflation.

Read full article arrow
News Thumbnail